INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $79,000 | -82.2% | 1,428 | -83.4% | 0.01% | -85.4% |
| Q2 2022 | $445,000 | -1.8% | 8,613 | +154.8% | 0.04% | +24.2% |
| Q3 2021 | $453,000 | +1787.5% | 3,380 | +644.5% | 0.03% | +1550.0% |
| Q4 2020 | $24,000 | – | 454 | +2170.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 20 | -99.5% | 0.00% | -100.0% |
| Q4 2019 | $55,000 | -23.6% | 3,759 | -30.9% | 0.01% | -28.6% |
| Q3 2019 | $72,000 | +350.0% | 5,440 | +444.0% | 0.01% | +250.0% |
| Q2 2019 | $16,000 | -61.0% | 1,000 | -33.6% | 0.00% | -33.3% |
| Q2 2018 | $41,000 | +51.9% | 1,506 | +17.1% | 0.00% | +50.0% |
| Q1 2018 | $27,000 | +42.1% | 1,286 | +29.9% | 0.00% | 0.0% |
| Q4 2017 | $19,000 | – | 990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |